JettSet1 Enterprises

JettSet1 Enterprises is a diversified venture studio and holding company co-founded by George Jett and Clifford Smith Jr., also known as Method Man. The company's life sciences division, JettSet1 Bio, is a clinical-stage biotechnology firm specializing in the development of targeted radiopharmaceuticals and immunotherapies. Its primary focus is on addressing unmet needs in oncology and rare diseases through the acquisition and advancement of high-potential therapeutic assets. JettSet1 Bio utilizes a platform-based approach to deliver potent isotopes directly to cancer cells while minimizing off-target effects. The company leverages strategic partnerships with leading academic and research institutions to fuel its pipeline. By combining deep industry expertise with a unique venture model, JettSet1 Enterprises aims to accelerate the delivery of transformative medicines to patients.